IP Verse

Crispr/Cas Related Methods And Compositions For Treating Cystic Fibrosis - EP3129485

PATENT ANALYSIS

Patent Details

Grant Date
Dec 21, 2022
Company
EDITAS MEDICINE, INC.
Oppositions

JAMES POOLE LIMITED

More patents of Editas Medicine, Inc.

EP3129485

EP3066201

Want to monitor this patent?

Feel free to send us a message here and we will get back to you